Literature DB >> 28569084

The Correlates of Quality of Life Among Jordanian Patients With Schizophrenia.

Ahmad Rayan1, Khaldoon Obiedate2.   

Abstract

BACKGROUND: Addressing the quality of life (QOL) of patients with schizophrenia is of special importance in the Arab world, where little knowledge is available about their well-being, and most of them experience stigma and living in poverty. AIMS: The purpose of this study was to examine the association of sociodemographic characteristics, severity of depressive symptoms, and various aspects of public stigma against mental illness, with QOL among Jordanian patients with schizophrenia.
METHOD: In this descriptive correlational study, 160 Jordanian outpatients diagnosed with schizophrenia completed measures of demographic characteristics, perceived public stigma against mental illness, severity of depression, and QOL.
RESULTS: Participants had poor QOL. Age, marital status, relapse, education level, stigma against mental illness, and severity of depression were significantly associated with QOL among Jordanian patients with schizophrenia. Data analysis revealed that the severity of depression accounted for an additional 27% of the variance above and beyond the 36.7% accounted for by age of the participants and perceived public stigma against mental illness.
CONCLUSIONS: Health care professionals should develop culturally competent nursing practice considering the specific factors associated with QOL among Arab patients with schizophrenia.

Entities:  

Keywords:  Arab; Jordan; quality of life; schizophrenia; stigma

Mesh:

Year:  2017        PMID: 28569084     DOI: 10.1177/1078390317710498

Source DB:  PubMed          Journal:  J Am Psychiatr Nurses Assoc        ISSN: 1078-3903            Impact factor:   2.385


  4 in total

Review 1.  A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries.

Authors:  Jeremy C Kane; Melissa A Elafros; Sarah M Murray; Ellen M H Mitchell; Jura L Augustinavicius; Sara Causevic; Stefan D Baral
Journal:  BMC Med       Date:  2019-02-15       Impact factor: 8.775

2.  Phenome-wide and genome-wide analyses of quality of life in schizophrenia.

Authors:  Raha Pazoki; Bochao Danae Lin; Kristel R van Eijk; Dick Schijven; Sonja de Zwarte; Sinan Guloksuz; Jurjen J Luykx
Journal:  BJPsych Open       Date:  2020-12-09

3.  Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.

Authors:  Mélissa Beaudoin; Alexandre Hudon; Charles-Edouard Giguère; Stéphane Potvin; Alexandre Dumais
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-21

4.  Schizophrenia in the context of mental health services in Palestine: a literature review.

Authors:  Mohammad Marie; Zareefa Shaabna; Manahel Saleh
Journal:  Int J Ment Health Syst       Date:  2020-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.